Table 1.
Baseline demographics and clinical characteristics of the study population stratified by COVID-19 severity.
| Variable | All (n = 289) |
COVID-19 Severity |
p-value | ||
|---|---|---|---|---|---|
| ICU (n = 88) |
Non-ICU (n = 201) |
||||
| Age, median (IQR), years | 59 (48.5–71) | 69 (59–77) | 54 (44.5–65) | < 0.001 | |
| Hospital admission, median (IQR), days | 8 (5.5–12) | 12 (8–19) | 7 (5–10) | < 0.001 | |
| Gender, n (%) | |||||
| Male | 175 (60.6) | 53 (30.3) | 122 (69.7) | 0.94 | |
| Female | 114 (39.4) | 35 (30.7) | 79 (69.3) | ||
| In-hospital Mortality, n (%) | |||||
| Yes | 42 (14.5) | 41 (97.6) | 1 (2.4) | < 0.001 | |
| No | 247 (85.5) | 47 (19) | 200 (81) | ||
| Symptoms in admission, n (%) | |||||
| Fever | 214 (74) | 67 (31.3) | 147 (68.7) | 0.592 | |
| Cough | 229 (79.2) | 66 (28.8) | 163 (71.2) | 0.24 | |
| Diarrhea and/or vomiting | 61 (21.1) | 10 (16.4) | 51 (83.6) | 0.007 | |
| Anorexia | 133 (46) | 38 (28.6) | 95 (71.4) | 0.522 | |
| Dyspnea | 245 (84.8) | 80 (32.7) | 165 (67.3) | 0.055 | |
| Fatigue | 266 (92) | 81 (30.5) | 185 (69.5) | 0.999 | |
| Comorbidities, n (%) | |||||
| Diabetes | 102 (35.3) | 39 (38.2) | 63 (61.8) | 0.034 | |
| Hypertension | 146 (50.5) | 62 (42.5) | 84 (57.5) | < 0.001 | |
| Cardiovascular diseases | 89 (30.8) | 41 (46.1) | 48 (53.9) | < 0.001 | |
| Renal diseases | 28 (9.7) | 16 (57.1) | 12 (42.9) | 0.001 | |
| Cancer | 10 (3.5) | 4 (40) | 6 (60) | 0.504 | |
| Multi-comorbidities | 125 (43.3) | 56 (44.8) | 69 (55.2) | 0.061 | |